VONVENDI DIN 02484420
Status: Approved
Holder: TAKEDA CANADA INC
Health Canada record
| Active ingredient(s) | VON WILLEBRAND FACTOR (RECOMBINANT) 650 UNIT |
|---|
| Dosage form | Powder For Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | SCHEDULE D |
|---|
| Class | Human |
|---|
| ATC | B02BD10 VON WILLEBRAND FACTOR |
|---|
| Original market date | |
|---|
| Current status date | 04-Feb-2021 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Takeda Canada Inc. — licence 101769, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing VON WILLEBRAND FACTOR (RECOMBINANT)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02484439 | VONVENDI | TAKEDA CANADA INC | Powder For Solution | VON WILLEBRAND FACTOR (RECOMBINANT) 1300 UNIT | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 21714 | 2019-01-10 | New Drug Submission (NDS) | |
Request a quote for VONVENDI
How to read a Canadian DIN record